Isotretinoin-induced myositis
- PMID: 38532764
- PMCID: PMC10962232
- DOI: 10.1093/omcr/omae017
Isotretinoin-induced myositis
Abstract
Retinoid-induced myositis is a phenomenon recognised in multiple case reports. We report a case of isotretinoin-induced myositis in an 18-year-old male patient. This case adds to the published literature as it demonstrates (i) myositis may occur after extended periods of isotretinoin use, (ii) should be considered as a differential diagnosis even when presenting asymmetrically and (iii) can continue to progress clinically and biochemically initially following the suspension of isotretinoin before being effectively treated with corticosteroids.
© The Author(s) 2024. Published by Oxford University Press.
Conflict of interest statement
None.
Figures
References
-
- Melnik BC. Apoptosis may explain the pharmacological mode of action and adverse effects of isotretinoin, including teratogenicity. Acta Derm Venereol 2017;97:173–81. - PubMed
-
- Brzezinski P, Borowska K, Chiriac A, Smigielski J. Adverse effects of isotretinoin: a large, retrospective review. Dermatol Ther 2017;30:e12483. - PubMed
-
- Marson JW, Baldwin HE. The creatine kinase conundrum: a reappraisal of the association of isotretinoin, creatine kinase, and rhabdomyolysis. Int J Dermatol 2020;59:279–83. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
